These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9103917)
41. Unplanned admissions to two Sydney public hospitals after naltrexone implants. Little M; Murray LM Med J Aust; 2008 Oct; 189(8):469; author reply 470-1. PubMed ID: 19024885 [No Abstract] [Full Text] [Related]
42. Unplanned admissions to two Sydney public hospitals after naltrexone implants. Lloyd-Jones DM Med J Aust; 2008 Oct; 189(8):468-9; author reply 470-1. PubMed ID: 18928445 [No Abstract] [Full Text] [Related]
43. Naltrexone for opioid dependence. An additional tool for general practitioners. Tedeschi M Aust Fam Physician; 2002 Jan; 31(1):18-20. PubMed ID: 11840882 [TBL] [Abstract][Full Text] [Related]
44. Treating cancer pain in patients addicted to drugs. J Support Oncol; 2007 Feb; 5(2):63-4. PubMed ID: 17348357 [No Abstract] [Full Text] [Related]
45. Unplanned admissions to two Sydney public hospitals after naltrexone implants. Kozminsky MP Med J Aust; 2008 Oct; 189(8):469-70; author reply 470-1. PubMed ID: 19031547 [No Abstract] [Full Text] [Related]
47. The use of depot naltrexone under legal coercion: the case for caution. Hall W; Capps B; Carter A Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728 [No Abstract] [Full Text] [Related]
48. Opioid overdose deaths can occur in patients with naltrexone implants. Hulse GK; Tait RJ Med J Aust; 2007 Jul; 187(1):54; author reply 56-7. PubMed ID: 17605708 [No Abstract] [Full Text] [Related]
50. Informed consent abandoned--patient given contraindicated drug. Gregg M; Martinez L; Samaritan G J Med Assoc Ga; 2014; 103(2):22. PubMed ID: 25185350 [No Abstract] [Full Text] [Related]
51. [Acalculous cholecystitis and drug addiction]. Buti M; Esteban R; Sureda DG; Genescá J; Guardia J Med Clin (Barc); 1985 Jun; 85(2):82. PubMed ID: 4021620 [No Abstract] [Full Text] [Related]
52. [Amenorrhea in drug dependence]. Bellati U; Noia G; Conte M; Mazzei R; Tempesta E Minerva Med; 1983 Apr; 74(16):865-8. PubMed ID: 6843872 [TBL] [Abstract][Full Text] [Related]
53. XXIX. The basis and possible utility of the use of opioid antagonists in the ambulatory treatment of the addict. Martin WR Res Publ Assoc Res Nerv Ment Dis; 1968; 46():367-77. PubMed ID: 5723804 [No Abstract] [Full Text] [Related]
54. [The need for psychopharmacologic therapy of drug addicts with acute hepatitis]. Rizzo F Clin Ter; 1984 Oct; 111(1):69-73. PubMed ID: 6149840 [No Abstract] [Full Text] [Related]
55. Extended-release intramuscular naltrexone in alcohol dependence in adults: profile report. Swainston Harrison T; Plosker GL; Keam SJ CNS Drugs; 2007; 21(1):83-7. PubMed ID: 17190531 [No Abstract] [Full Text] [Related]
57. A free clinic approach to drug abuse. Gay GR; Smith DE Prev Med; 1973 Dec; 2(4):543-53. PubMed ID: 4778462 [No Abstract] [Full Text] [Related]
58. [New supportive therapy with naltrexone. Care of heroin addiction in the United States]. Rimailho A Rev Prat; 1987 May; 37(29):1751-5. PubMed ID: 3589443 [No Abstract] [Full Text] [Related]
59. Carbon dioxide therapy (CDT) of addictions. La Verne AA PDM; 1973; 4-5(9-12;1-8):63-82. PubMed ID: 4802418 [No Abstract] [Full Text] [Related]
60. Changing medical complications of illicit drug use. Becker CE Calif Med; 1973 Aug; 119(2):69-70. PubMed ID: 4726952 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]